Search details
1.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37290468
2.
Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma.
BMC Cancer
; 23(1): 7, 2023 Jan 03.
Article
in English
| MEDLINE | ID: mdl-36597072
3.
Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
Eur Radiol
; 33(5): 3682-3692, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36735041
4.
Head and neck MRI-based T stage and [18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma.
Eur Radiol
; 33(11): 7952-7966, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37314471
5.
Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.
BMC Cancer
; 22(1): 1129, 2022 Nov 03.
Article
in English
| MEDLINE | ID: mdl-36329397
6.
Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
Ann Surg Oncol
; 28(8): 4542-4550, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33492543
7.
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 48(8): 2586-2598, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33420610
8.
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
BMC Cancer
; 21(1): 534, 2021 May 11.
Article
in English
| MEDLINE | ID: mdl-33975558
9.
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
BMC Cancer
; 21(1): 1320, 2021 Dec 09.
Article
in English
| MEDLINE | ID: mdl-34886807
10.
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Eur Radiol
; 31(7): 5222-5233, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33416977
11.
Molecular cloning, the characterization of metallothionein and catalase, and the evaluation of testicular toxicity of Cd in the Chinese fire-bellied newt (Cynops orientalis).
Ecotoxicol Environ Saf
; 208: 111731, 2021 Jan 15.
Article
in English
| MEDLINE | ID: mdl-33396062
12.
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
BMC Cancer
; 20(1): 89, 2020 Feb 03.
Article
in English
| MEDLINE | ID: mdl-32013967
13.
Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
BMC Cancer
; 19(1): 908, 2019 Sep 11.
Article
in English
| MEDLINE | ID: mdl-31511059
14.
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
BMC Cancer
; 19(1): 92, 2019 Jan 21.
Article
in English
| MEDLINE | ID: mdl-30665378
15.
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.
J Natl Compr Canc Netw
; 17(6): 703-710, 2019 06 01.
Article
in English
| MEDLINE | ID: mdl-31200353
16.
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 19(4): 461-473, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29501366
17.
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis.
BMC Cancer
; 18(1): 1297, 2018 Dec 29.
Article
in English
| MEDLINE | ID: mdl-30594171
18.
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
BMC Cancer
; 18(1): 1279, 2018 Dec 20.
Article
in English
| MEDLINE | ID: mdl-30572856
19.
[Ambient VOCs Characteristics and Reactivity During O3 Pollution in Autumn in Urban Beijing].
Huan Jing Ke Xue
; 44(2): 691-698, 2023 Feb 08.
Article
in Zh
| MEDLINE | ID: mdl-36775593
20.
[Variation Characteristics and Ozone Formation Potential of Ambient VOCs in Urban Beijing in Summer].
Huan Jing Ke Xue
; 44(4): 1954-1961, 2023 Apr 08.
Article
in Zh
| MEDLINE | ID: mdl-37040946